ory continues to unfold,” Dr. LaDu and Dr. Tai wrote in an e-mail.
•. Verghese PB, Castellano JM, Holtzman DM. ApoE influences amyloid-β(Aβ) clearance despite minimal apoE/Aβ association in physiological conditions. Proc Natl Acad Sci. U S A. 2013; 110:(19):E1807-;16. E-pub 2013 Apr 25.
•. Tai LM, Bilousova T, Ladu MJ. Levels of soluble apolipoprotein E/amyloid-β (Aβ) complex are reduced and oligomeric Aβ Increased with APOE4 and Alzheimer disease in a transgenic mouse model and human samples. J Biol Chem. 2013; 288:5914–5926.
•. Neurology Today: “Increased LDL receptor lowers amyloid plaques via apolipoprotein E: Study offers new insight on how APOE works in Alzheimer disease”: http://bit.ly/119w0V6